This information is intended only for healthcare professionals resident in the United Kingdom


Prescribing Information (PI) for Zavicefta (ceftazidime and avibactam) Great Britain (GB) and Northern Ireland (NI) and Meronem (meropenem trihydrate), Amikacin (amikacin (as sulphate)) and Tazocin (piperacillin sodium, tazobactam sodium) United Kingdom (UK)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Zavicefta (ceftazidime and avibactam) 2g/0.5g powder for concentrate for solution for infusion - PI for GB

Northern Ireland

  • Zavicefta (ceftazidime and avibactam) 2g/0.5g powder for concentrate for solution for infusion - PI for NI

United Kingdom

  • Tazocin (piperacillin sodium, tazobactam sodium) 2g/0.25g Powder for Solution for Infusion PI for UK
    ​​​​​​​
    Tazocin (piperacillin sodium, tazobactam sodium) 4g/0.5g powder for solution for infusion - PI for UK

United Kingdom

  • Meronem (meropenem trihydrate)  IV 1g - PI for UK
    ​​​​​​​
    Meronem (meropenem trihydrate) IV 500mg - PI for UK

United Kingdom

  • Amikacin (amikacin (as sulphate)) 250 mg/ml Injection - PI for UK

Zavicefta (ceftazidime and avibactam) 2g/0.5g powder for concentrate for solution for infusion - PI for GB

Zavicefta (ceftazidime and avibactam) 2g/0.5g powder for concentrate for solution for infusion - PI for NI

Tazocin (piperacillin sodium, tazobactam sodium) 2g/0.25g Powder for Solution for Infusion PI for UK

Tazocin (piperacillin sodium, tazobactam sodium) 4g/0.5g powder for solution for infusion - PI for UK

Meronem (meropenem trihydrate)  IV 1g - PI for UK

Meronem (meropenem trihydrate) IV 500mg - PI for UK

Amikacin (amikacin (as sulphate)) 250 mg/ml Injection - PI for UK

PP-ZVA-GBR-1448 March 2022